Merck Co. Inc. stock outperforms competitors on strong trading day - MarketWatch
| MRK Stock | 143.15 1.05 0.73% |
Slightly above 61% of Merck KGaA's investor base is looking to short. The analysis of current outlook of investing in Merck KGaA suggests that many traders are alarmed regarding Merck KGaA's prospects. Merck KGaA's investing sentiment can be driven by a variety of factors including economic data, Merck KGaA's earnings reports, geopolitical events, and overall market trends.
Merck |
Merck Co. Inc. stock outperforms competitors on strong trading day MarketWatch
Read at news.google.com
 |
Merck KGaA Fundamental Analysis
We analyze Merck KGaA's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Merck KGaA using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Merck KGaA based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Total Debt
Total Debt Comparative Analysis
Merck KGaA is currently under evaluation in total debt category among its peers. Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Merck KGaA Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Merck KGaA stock to make a market-neutral strategy. Peer analysis of Merck KGaA could also be used in its relative valuation, which is a method of valuing Merck KGaA by comparing valuation metrics with similar companies.
Peers
Merck KGaA Related Equities
| 2DG | SIVERS SEMICONDUCTORS | 6.25 | ||||
| 3RKU | RYOHIN UNSPADR1 | 3.92 | ||||
| MEL | Meli Hotels | 2.87 | ||||
| HEI | Heidelberg Materials | 2.63 | ||||
| IDP | Biogen | 1.49 | ||||
| 8SP | Superior Plus | 0.91 | ||||
| VUSA | Vanguard Funds | 0.90 | ||||
| CJH | CanSino Biologics | 0.50 |
Additional Tools for Merck Stock Analysis
When running Merck KGaA's price analysis, check to measure Merck KGaA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Merck KGaA is operating at the current time. Most of Merck KGaA's value examination focuses on studying past and present price action to predict the probability of Merck KGaA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Merck KGaA's price. Additionally, you may evaluate how the addition of Merck KGaA to your portfolios can decrease your overall portfolio volatility.